[PDF] Top 20 Políticas de formação de professores: o brasil no contexto da globalização
Has 10000 "Políticas de formação de professores: o brasil no contexto da globalização" found on our website. Below are the top 20 most common "Políticas de formação de professores: o brasil no contexto da globalização".
Direct activation of PP2A for the treatment of tyrosine kinase inhibitor–resistant lung adenocarcinoma
... of PP2A activators as therapeutic agents for the treatment of TKI-resistant ...that PP2A activation using SMAPs is a viable strategy for both TKI-sensitive and -resistant LUAD ... See full document
23
The impact of intermittent versus continuous exposure to EGFR tyrosine kinase inhibitor on selection of EGFR T790M-mutant drug-resistant clones in a lung cancer cell line carrying activating EGFR mutation
... drug treatment was less effectively induced the emergence of the EGFR T790M mutation which is the most common resistance mechanism found in EGFR-mutant lung cancer patients treated by EGFR-TKI, compared ... See full document
6
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
... cell lung cancer (NSCLC) cell lines harboring T790M mutations [17], the clinical trial did not show the overall survival benefit in patients after failure of platinum doublet and first-generation EGFR TKIs ...in ... See full document
36
<p>Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports</p>
... pathways activation and epithelial-mesenchymal transition and transformation into small cell lung carcinoma ...rst-line treatment of common sensitive EGFR mutations or for second line ... See full document
37
Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma
... (EGFR)-tyrosine kinase inhibitor (gefitinib) or a multi-targeted kinase inhibitor (sorafenib) in combination with a histone deacetylase inhibitor (vorinostat) on cell ... See full document
9
Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor
... initial treatment response was classified as a complete response (CR), partial response (PR), stable disease (SD), or progressive disease (PD) based on serial imaging studies using the revised Response Evaluation ... See full document
21
<em>EGFR</em> mutations as a prognostic and predictive marker in non-small-cell lung cancer
... The randomized Phase III First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never- Smokers With Adenocarcinoma of the Lung (First-SIGNAL) trial enrolled 313 Korean never-smokers with ... See full document
5
The predictive role of pretreatment epidermal growth factor receptor T790M mutation on the progression-free survival of tyrosine-kinase inhibitor-treated non-small cell lung cancer patients: a meta-analysis
... TKI treatment and PFS (when the patients were divided with a cutoff sensitivity of ...the treatment received (surgery) are factors that may account for this ... See full document
5
Sequential treatment of tyrosine kinase inhibitor and platinum-based doublet chemotherapy on EGFR mutant non-small cell lung cancer: a meta-analysis of randomized controlled clinical trials
... of EGFR, while the second generation irreversible. However, no clinical trial has yet indicated that second generation TKI improves PFS or OS significantly more than first generation TKIs. As all of them are recommended ... See full document
24
Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec<sup>®</sup>, Gleevec™)
... Mild fl uid retention and edema (often in the periorbital region) are other common dose-related toxicities of imatinib, occurring in about 50%–70% of the patients (Cohen et al 2002). For periorbital edema no specifi c ... See full document
11
Phospholipase C mediated hydrolysis of phosphatidylcholine is activated by cis diamminedichloroplatinum(II)
... membrane extract from PC-9 cells. CDDP had no effect on the activities of phospholipase A2 and D. Trans-DDP, which has far less cytotoxicity than its stereoisomer, CDDP, did not cause any change in PC-PLC activity. A ... See full document
13
<p>Tyrosine Kinase Inhibitor-Related Hepatotoxicity in Patients with Advanced Lung Adenocarcinoma: A Real-World Retrospective Study</p>
... Toxicity pro fi les are different for EGFR-TKIs harboring unique chemical structures. Although there have been no prospective trials comparing toxicity among different fi rst- line EGFR-TKIs, a meta-analysis and a pooled ... See full document
16
Original Article Comparative survival analysis of the treatment options for TKI resistant advanced non-small cell lung cancer (NSCLC) patients: a meta-analysis
... sustained activation of the phosphatidylinositol 3’-kinase-serine/thre- onine kinase Akt (PI3K/AKT) signalling path- way bypassing EGFR ...MET activation is associated with poor NSCLC ... See full document
121
<p>Targeted therapy and personalized medicine in gastrointestinal stromal tumors: drug resistance, mechanisms, and treatment strategies</p>
... the activation loop, is also associated with imatinib resistance, although most of these tumors seem to have low mitotic rates and an indolent clinical ...be resistant to imatinib, but they also tend to ... See full document
6
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper
... emerging resistant clones could be present below the detection limit of Sanger sequencing and might thus not be identified in a timely manner, ultimately leading to treatment ...highly resistant to ... See full document
5
Multiple domain 'nexus' proteins in receptor-mediated cell signaling
... In addition to their originally described roles as Gα GAPs and negative regulators of GPCR signaling [266], RGS proteins increasingly appear to serve as scaffolds that integrate signaling from diverse receptors and steer ... See full document
11
Systematic review of dasatinib in chronic myeloid leukemia
... intermittent treatment regimen using a starting dose of 100 mg once daily is the safest and most effective dose, and this is now recommended for chronic phase ...first-line treatment for newly diagnosed ... See full document
58
MERTK receptor tyrosine kinase is a therapeutic target in melanoma
... to activation with either 200 nM GAS6 (885-GS; R&D Systems) or control buffer for 10 ...and treatment for 90 minutes prior to activation with ...nadate treatment was used only to observe ... See full document
37
Effective treatment of pulmonary adenocarcinoma harboring triple EGFR mutations of L858R, T790M, and <em>cis</em>-C797S by osimertinib, bevacizumab, and brigatinib combination therapy: a case report
... targeted treatment of osimertinib (80 mg qd po), bevacizumab (15 mg/kg q3w) and brigatinib (100 mg qd ...of treatment (June 2017, Figure ...targeted treatment of osimertinib, bevacizumab, and ... See full document
6
TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis
... exposure, connective tissue diseases, drug injury) under- went blood tests for screening of connective tissues dis- eases (including; ANCA, ANA, rheumatic blood test, complement C3,C4) and upon negative results underwent ... See full document
55
Related subjects